3-D Matrix, Ltd. (DMTRF)

Market Cap	315.82M +91.9%
Revenue (ttm)	74.78M +55.9%
Net Income	23.17M
EPS	0.17
Shares Out	n/a
PE Ratio	13.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Open	1.110
Previous Close	2.500
Day's Range	1.110 - 2.500
52-Week Range	1.110 - 3.960
Beta	0.98
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 10, 2026

About 3-D Matrix

3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields; and surfactant-like peptide, as well as High Concentration PuraMatrix, a high concentration hydrogel; and GMP Grade PuraMatrix. The company was incorporated in 2004 and is based in Tokyo, Japan.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 129
• Stock Exchange: OTCMKTS
• Ticker Symbol: DMTRF

Financial Performance

Financial numbers in JPY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 11, 2026

Data Sources Report a data error